Merck KGaA (MRK)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 146.35 |
|---|---|
| 52-week range | 100.70 – 148.80 |
| Return, 1 month / 3 months | +9.9% / +6.9% |
| Return, 1 year / 3 years | +29.6% / +3.7% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 27.4% |
| Worst drawdown (1 year) | -21.7% |
| Average daily value traded | 37.09M EUR |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Merck KGaA is a science and technology company based in Darmstadt, Germany. It operates through three businesses: Life Science, which supplies laboratory tools, chemicals and services to research and pharmaceutical customers; Healthcare, which develops prescription medicines in areas such as oncology and fertility; and Electronics, which provides specialty materials and solutions for semiconductor and display manufacturers. The company serves customers in research laboratories, hospitals, pharmaceutical firms and the electronics industry around the world.
Merck KGaA trades under the code MRK on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Merck KGaA (MRK) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 146.35 on 22 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 34 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.6% and over the last three months it rose 6.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.3% | ||
| From 52-week high | -0.8% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.9% | ||
| 6-month return | 29.1% | ||
| 12-month return, skipping the last month | 18.0% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.7% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 37.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +9.9% |
| 3 months | +6.9% |
| 6 months | +29.1% |
| 1 year | +29.6% |
| 3 years | +3.7% |
| 5 years | −21.9% |
Signals
| 50-day / 200-day average | 137.19 / 128.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | EUR 2.2000 |
| 28 Apr 2025 | EUR 2.2000 |
| 29 Apr 2024 | EUR 2.2000 |
| 2 May 2023 | EUR 2.2000 |
| 25 Apr 2022 | EUR 1.8500 |
| 26 Apr 2021 | EUR 1.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.